NCT06750588View on ClinicalTrials.gov

Safety and Tolerability of NTR-101 in Patients With Acute Alcohol-Associated Hepatitis

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 5, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2026

Conditions
Alcohol-Associated Hepatitis
Interventions
DRUG

bacteriophage preparation

NTR-101 will be given orally to participants once daily for 7 days

DRUG

Bacteriophage preparation

NTR-101 will be given orally to participants once daily for 7 days

DRUG

bacteriophage preparation

NTR-101 will be given orally to participants twice daily for 7 days

DRUG

bacteriophage preparation

NTR-101 will be given orally to participants three times daily for 7 days

Trial Locations (1)

92118

Southern California Research Center, inc, Coronado

All Listed Sponsors
collaborator

Southern California Research Center

OTHER

lead

Nterica Bio inc

INDUSTRY